Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300078641Phase 4Not yet recruiting
Phase 4, randomised trial comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: QoR-15 scale scores. Planned start Dec 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300078641.